NAYA (NAYA Biosciences Inc) סך כל נכסי החברה

The market trend for NAYA Biosciences (NAYA), which specializes in oncology therapies, as shown on this price chart, demonstrates total assets at 12.33. This price action reflects a high concentration of capital in the development of targeted platforms, which entails binary risks. Global instability impacting biomaterial logistics hinders development, while business success depends on test results and the support of major medical centers.

The stability of NAYA Biosciences relies on access to capital for conducting oncology tests, while the total value of resources, reverse-calculated via ROA, reflects the balance between equity and liabilities. It is critical for investors to evaluate this metric as an indicator of financial stability or leverage risk, which the current level of total assets clearly demonstrates.